MarketCap
Facebook
X
TelegramCRH Medical Corporation Total Assets 2011-2026 | CRHM
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets CRH Medical Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 192 M | 203 M | 219 M | 198 M | 164 M | 104 M | 79 M | 8.63 M | 5.89 M | 4.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 219 M | 4.1 M | 118 M |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
25.8 B | $ 20.66 | 1.27 % | $ 10.5 B | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 205.09 | 1.16 % | $ 59 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
26.7 M | $ 8.15 | -7.6 % | $ 164 M | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
Harvard Bioscience
HBIO
|
137 M | $ 0.66 | -1.92 % | $ 28 M | USA |
 |
iRhythm Technologies
IRTC
|
931 M | $ 188.16 | 0.41 % | $ 5.87 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 138.18 | 0.8 % | $ 7.36 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 84.98 | 2.36 % | $ 4.28 B | USA |
 |
OraSure Technologies
OSUR
|
480 M | $ 2.65 | 5.38 % | $ 197 M | USA |
 |
Alcon
ALC
|
30.3 B | $ 80.67 | -0.38 % | $ 40.4 B |  Schweiz |
 |
Predictive Oncology
POAI
|
4.97 M | $ 6.85 | 3.24 % | $ 37.4 M | USA |
 |
AtriCure
ATRC
|
609 M | $ 42.59 | 1.96 % | $ 2 B | USA |
 |
electroCore
ECOR
|
16.1 M | $ 5.15 | 6.19 % | $ 28.4 K | USA |
 |
ICU Medical
ICUI
|
4.2 B | $ 152.88 | 1.7 % | $ 3.73 B | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 10.02 | -8.29 % | $ 409 M | USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 83.38 | -0.63 % | $ 16.6 B | USA |
 |
Isoray
ISR
|
341 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
10.1 B | $ 260.64 | 0.52 % | $ 25.7 B | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 114.49 | 0.43 % | $ 5.55 B | USA |
 |
InfuSystem Holdings
INFU
|
99.4 M | $ 8.9 | -0.11 % | $ 184 M | USA |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 5.79 | 3.02 % | $ 264 M | USA |
 |
LeMaitre Vascular
LMAT
|
552 M | $ 85.05 | 1.55 % | $ 1.91 B | USA |
 |
Intuitive Surgical
ISRG
|
18.7 B | $ 586.15 | -1.03 % | $ 208 B | USA |
 |
Merit Medical Systems
MMSI
|
2.42 B | $ 93.33 | 1.83 % | $ 5.43 B | USA |
 |
Utah Medical Products
UTMD
|
135 M | $ 58.5 | 1.39 % | $ 212 M | USA |
 |
Nephros
NEPH
|
11.9 M | $ 5.07 | -1.74 % | $ 52.7 M | USA |
 |
Microbot Medical
MBOT
|
8.33 M | $ 2.19 | 3.55 % | $ 22.3 M |  Israel |
 |
Milestone Scientific
MLSS
|
9.8 M | $ 0.29 | 2.24 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.35 B | $ 23.52 | 2.53 % | $ 4.05 B | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 41.83 | 4.47 % | $ 138 M | USA |
 |
Pulse Biosciences
PLSE
|
59.2 M | $ 14.71 | -3.26 % | $ 707 M | USA |
 |
Repligen Corporation
RGEN
|
2.83 B | $ 165.12 | -2.32 % | $ 9.2 M | USA |
 |
ResMed
RMD
|
5.1 B | $ 250.85 | 1.07 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
399 M | $ 24.91 | -1.97 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
41.9 M | $ 2.57 | -1.35 % | $ 207 M | USA |
 |
Retractable Technologies
RVP
|
161 M | $ 0.76 | -0.53 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
510 M | $ 22.43 | 1.08 % | $ 1.1 B | USA |
 |
Teleflex Incorporated
TFX
|
7.1 B | $ 110.0 | -13.07 % | $ 5.15 B | USA |
 |
West Pharmaceutical Services
WST
|
3.64 B | $ 274.0 | -1.62 % | $ 20 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.75 B | $ 12.53 | 1.25 % | $ 2.55 B | USA |